Evidence map›Paper›PMID 33742315›Full record

ArticleInternational urology and nephrology2021

microRNA-29b prevents renal fibrosis by attenuating renal tubular epithelial cell-mesenchymal transition through targeting the PI3K/AKT pathway.

Shuang Hu, Hongtao Hu, Rui Wang, Hong He, Hua Shui

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in International urology and nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Molecular and Cellular Mediators of Renal Fibrosis in Lupus Nephritis.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Exogenous HSleep & breathing = Schlaf & Atmung · 2024
    Article
  8. Article
  9. The role of PI3K/Akt signaling pathway in chronic kidney disease.International urology and nephrology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shuang HuDepartment of Nephrology, Zhongnan Hospital, Wuhan University, No.169, Road East lake, Wuhan, 430071, Hubei, People's Republic of China.
Hongtao HuDepartment of Intensive Care Unit, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, 430071, People's Republic of China.
Rui WangDepartment of Nephrology, Zhongnan Hospital, Wuhan University, No.169, Road East lake, Wuhan, 430071, Hubei, People's Republic of China.
Hong HeDepartment of Nephrology, Zhongnan Hospital, Wuhan University, No.169, Road East lake, Wuhan, 430071, Hubei, People's Republic of China.
Hua ShuiDepartment of Nephrology, Zhongnan Hospital, Wuhan University, No.169, Road East lake, Wuhan, 430071, Hubei, People's Republic of China. shuihua@whu.edu.cn.ORCID http://orcid.org/0000-0002-5504-0822
Wuhan University · CN

Funding

The Joint Fund of Health Commission of Hubei Province WJ2019H024
6 · The paper itself

Abstract

purposeThis study aimed to investigate the effects of miR-29b on renal interstitial fibrosis in the obstructed kidney of mouse with unilateral ureteral obstruction (UUO) via inhibiting phosphatidylinositol 3-kinase/protein kinaseB (PI3K/AKT) signaling pathway.

methodsAdult male CD-1 mice were intraperitoneally injected with vehicle or PI3K inhibitor LY294002 (3 mg/kg, 30 mg/kg) daily for 1 or 2 weeks after performing UUO or sham operation. The mice were sacrificed on days 7 and 14 after surgery. The rat proximal tubular epithelial cell (TEC) line NRK-52E was cultured in DMEM and treated with various concentrations angiotensin II (AngII). Obstructed and sham mouse kidneys were analyzed via HE, Masson and immunohistochemistry to assess the degree of renal fibrosis. Real-time quantitative polymerase chain reaction assays (RT-PCR) were performed to investigate changes in the levels of expression of miR-29b and Western blot was used to analyze the activation of PI3K/AKT signaling and expression of E-cadherin, α-smooth muscle actin (α-SMA).

resultsHistologic analyses of obstructed kidney revealed that LY294002 attenuated the degree of renal fibrosis. In this study, loss of miR-29b accompanied with increased epithelial-mesenchymal transition (EMT) was observed in renal tubules of mice after UUO and cultured NRK-52E cells exposed to AngII. LY294002 also prominently decreased phosphorylation of AKT in vivo and vitro. By RT-PCR and Western blot analysis, LY294002 blocked the PI3K/AKT-induced loss of E-cadherin expression and de novo increase of the expression of α-SMA in a time- and dose-dependent manner. The overexpression of miR-29b markedly reversed the phenotype induced by AngII in NRK-52E cells and the downregulation miR-29b expression with an miR-29b inhibitor resulted in enhanced EMT. In addition, the PI3K/AKT signaling pathway was found to be suppressed in the presence of overexpression of miR-29b by direct hybridization with 3'-untranslated region (3'-UTR) of PIK3R2.

conclusionOur findings suggested that miR-29b significantly prevented tubulointerstitial injury in mouse model of UUO by attenuating renal tubular epithelial cell-mesenchymal transition via repressing PI3K/AKT signaling pathway.

Indexed as

AnimalsCells, CulturedEpithelial-Mesenchymal TransitionFibrosisKidneyKidney TubulesMaleMiceMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsUrotheliumMicroRNAsMIRN29 microRNA, mousePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAngiotensin-IIEpithelial–mesenchymal transitionMicroRNA-29bNRK-52E cellsPhosphatidylinositol 3-kinase/protein kinase BUnilateral ureteral obstruction

Identifiers

PMID33742315
PMCPMC8380229
OpenAlexW3136753862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.